Lauren Cipriano

Lauren Cipriano is an Associate Professor in Management Science at the Ivey Business School. She holds cross appointments in the Department of Medicine and the Department of Epidemiology and Biostatistics at the Schulich School of Medicine & Dentistry.

Dr. Cipriano’s research expertise focuses on the application of statistics, decision analysis, economics, and operations research to health policy problems. She has specific expertise in the economic evaluation of clinical diagnostics and novel therapeutics, resource allocation, and infectious disease policy. Dr. Cipriano holds a Canada Research Chair in Healthcare Analytics, Management, and Policy.

Dr. Cipriano has consulted for the World Health Organization, US Veterans Health Administration, US Centers for Medicare and Medicaid Services, the US Institute for Clinical and Economic Review, and the Canadian Agency for Drugs and Technologies in Health (CADTH). During the pandemic, Dr. Cipriano served on the Ontario COVID-19 Science Advisory Table’s Modelling Consensus Table.

Dr. Cipriano sits on the Health Economics Methods Advisory Committee for the Canadian Agency for Drugs and Technologies in Health (CADTH) and was awarded the Dr. Maurice McGregor Award for Health Technology Assessment in 2018.

Dr. Cipriano is the Deputy Editor of the journals Medical Decision Making and MDM Policy & Practice.

Dr. Cipriano received her MS in Statistics and PhD in Management Science and Engineering from Stanford University. She previously worked at the Ontario Joint Replacement Registry at London Health Sciences Centre and the Institute for Technology Assessment at Massachusetts General Hospital.

Dr. Cipriano joined Ivey in 2013. At Ivey, Dr. Cipriano teaches undergraduate Decision Making with Analytics and graduate courses in Business Analytics and Statistics.

Teaching

• Decision Making with Analytics, HBA core
• Multivariate Stats, PhD

Education

• B.Sc., Honors Biochemistry, Western University
• HBA, Ivey Business School, Western University
• M.S., Statistics, Stanford University
• Ph.D., Management Science, Stanford University

Recent Refereed Articles

• Hafeez, A.; Cipriano, L. E.; Kim, R.; Zaric, G.; Schwarz, U.; Sarma, S., 2023, "Cost‑Effectiveness Analysis of Pharmacogenomics (PGx)‑Based Warfarin, Apixaban, andRivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada", Pharmacoeconomics
• Roseborough, A. D.; Saad, L.; Goodman, M.; Cipriano, L. E.; Hachinski, V. C.; Whitehead, S. N., 2023, "White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta‐analysis, systematic review, and recommendations for future study harmonization", Alzheimers & Dementia, January 19(1): 194 - 207.
• Vilches, T. N.; Abdollahi, E.; Cipriano, L. E.; Haworth-Brockman, M.; Keynan, Y.; Sheffield, H.; Langley, J. M.; Moghadas, S. M., 2022, "Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study", Bmc Public Health, May 22(1): 1042 - 1042.
• Bansback, N. J.; Barbosa, C.; Barocas, J.; Bayoumi, A. M.; Behrends, C.; Chhatwal, J.; Cipriano, L. E.; Coffin, P.; Goldhaber-Fiebert, J. D.; Hoch, J., et al., 2021, "How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value", International Journal of Drug Policy, April 88: 102726 - 102726.
• Yarmol-Matusiak, E. A.; Cipriano, L. E.; Stranges, S., 2021, "A comparison of COVID-19 epidemiological indicators in Sweden, Norway, Denmark, and Finland", SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, February 49(1): 69 - 78.
• Fairley, M.; Cipriano, L. E.; Goldhaber-Fiebert, J. D., 2020, "Optimal Allocation of Research Funds under a Budget Constraint", Medical Decision Making, August 40(6): 797 - 814.
• Roseborough, A. D.; Langdon, K. D.; Hammond, R.; Cipriano, L. E.; Pasternak, S. H.; Whitehead, S. N.; Khan, A. R., 2020, "Post-mortem 7 Tesla MRI detection of white matter hyperintensities: A multidisciplinary voxel-wise comparison of imaging and histological correlates", NeuroImage: Clinical, July 27
• Azarpazhooh, M. R.; Avan, A.; Cipriano, L. E.; Munoz, D. G.; Erfanian, M.; Amiri, A.; Stranges, S.; Hachinski, V., 2020, "A third of community-dwelling elderly with intermediate and high level of Alzheimer's neuropathologic changes are not demented: A meta-analysis", Ageing Research Reviews, March 58
• Cipriano, L. E.; Goldhaber-Fiebert, J. D., 2019, "Population health and cost-effectiveness implications of a “treat all” recommendation for HCV: A review of the model-based evidence", Medical Decision Making: Policy & Practice, June 3(1)
• Chehrazi, N.; Cipriano, L. E.; Enns, E. A., 2019, "Dynamics of drug resistance: Optimal control of an infectious disease", Operations Research, June 67(3): 599 - 904.
• Ma, C.; Guizzetti, L.; Cipriano, L. E.; Parker, C.; Nguyen, T.; Gregor, J.; Chande, N.; Feagan, B.; Jairath, V., 2019, "Systematic review and meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies", Alimentary Pharmacology and Therapeutics, February 49(4): 364 - 374.
• Cerasuolo, J. O.; Azarpazhooh, M. R.; Kapral, M. K.; Cipriano, L. E.; Hachinski, V., 2019, "Evidence of Concomitantly Increasing Stroke and Dementia Prevalence among those 80 Years and Older in Ontario, Canada, 2003-04 to 2012-13", Canadian Journal of Neurological Sciences, January 46(1): 105 - 107.
• Sheehan, D.; Criss, S.; Chen, Y.; Eckel, A.; Palazzo, L.; Tramontano, A.; Hur, C.; Cipriano, L. E.; Kong, C. Y., 2019, "Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare", Cancer Medicine, January 8(1): 94 - 103.
• Mickle, K.; Lasser, K. E.; Hoch, J. S.; Cipriano, L. E.; Dreitlein, W. B.; Pearson, S. D., 2019, "The effectiveness and value of patisiran and inotersen for hereditary transthyretin amyloidosis: A summary from the Institute for Clinical and Economic Review’s midwest comparative effectiveness public advisory council", Journal of Managed Care and Specialty Pharmacy, January 25(1): 10 - 15.
• Cipriano, L. E.; Weber, T. A., 2018, "Population-level intervention and information collection in dynamic healthcare policy", Health Care Management Science, December 21(4): 604 - 631.

Honours & Awards

• Decision making in dynamic systems with strategic information acquisition” Natural Sciences and Engineering Research Council of Canada (NSERC)
• Seth Bonder Foundation Research Award, 2012
• Lee B. Lusted Student Prize Award for outstanding presentations of research in Applied Health Economics, Annual Meeting of the Society for Medical Decision Making, 2012
• Course Assistant Award, Department of Management Science & Engineering, Stanford University, 2012
• Seth Bonder Scholarship for Applied Operations Research in Health Services, INFORMS, 2011
• Award for Outstanding Short Course, Annual Meeting of the Society for Medical Decision Making, 2010, 2011
• Centennial Teaching Assistant Award, Stanford University, 2011

Experience

• Visiting Researcher, Management of Technology and Entrepreneurship Institute (MTEI), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland (Spring 2012)
• Research Scientist. Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA (2006-2008)
• Queuing Project Manager, Ontario Joint Replacement Registry, London Health Sciences Centre, London, ON (2004-2006)